Document is current
Any future updates will be listed below
-
Authors
Saito, Tatsushi
Karasawa, Hideaki https://orcid.org/0000-0003-0358-3398
Ouchi, Kota
Ono, Tomoyuki
Kajiwara, Taiki
Kohyama, Atsushi
Ikeda-Ohtsubo, Wakako
Fukuda, Shinji
Fujishima, Fumiyoshi
Ozawa, Yohei
Suzuki, Hideyuki
Watanabe, Kazuhiro
Ishioka, Chikashi
Kamei, Takashi
Ohnuma, Shinobu
Abe, Takaaki
Unno, Michiaki
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP22ek0210133)
Japan Agency for Medical Research and Development (JP23zf0127001)
Japan Society for the Promotion of Science (JSPS) KAKENHI (JP23fk0108655, 24K11819)
Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 3 June 2025
First Online: 16 June 2025
Declarations
:
: Chikashi Ishioka received research funding from Hitachi and Riken Genesis and honoraria from Chugai and Taiho. Michiaki Unno received research funding from Taiho and honoraria from AstraZeneca, MSD, and Taiho. The remaining authors have declared no conflict of interest.
: This study was approved by the Research Ethics Committee of the Tohoku University Graduate School of Medicine (No. 2020-1-1054).
: Written informed consent was obtained from each patient with CRC.
